Related by context. All words. (Click for frequent words.) 66 interpersonal psychotherapy 63 antidepressant therapy 62 neuroleptic 61 amisulpride 61 Symptom severity 60 Comorbid 60 SSRI SNRI 60 Pharmacologic 60 neurocognitive deficits 60 androgen ablation 60 poststroke depression 59 agomelatine 59 overactive bladder symptoms 59 antiangiogenic therapy 59 interferon ribavirin 59 comorbid anxiety 59 pharmacologic treatments 59 primidone 59 INVEGA ® 59 Generalized Anxiety Disorder 59 comorbid disorders 59 APTIVUS r 59 alexithymia 59 somatic symptoms 59 pharmacological interventions 59 comorbid depression 59 mania hypomania 59 euthymic 58 serotonin reuptake inhibitors 58 hepatic insufficiency 58 interpersonal psychotherapy IPT 58 Venous thromboembolism 58 venlafaxine XR 58 MBCT 58 Interpersonal psychotherapy 58 aldosterone antagonists 58 EXJADE 58 pyridostigmine 58 tryptophan depletion 58 Acute Coronary Syndromes ACS 58 VADT 58 inhaled budesonide 58 Atypical antipsychotics 58 Antipsychotic 58 AGILECT R 58 citalopram Celexa 58 adenotonsillectomy 58 venlafaxine Effexor 58 Major Depressive Disorder MDD 58 EDSS scores 58 preoperative chemotherapy 58 morphometric vertebral fractures 58 divalproex 58 fluoxetine Prozac 58 elevated ALT 57 visilizumab 57 SSRI antidepressant 57 ziconotide 57 euthymic patients 57 anticholinergic agents 57 nortriptyline 57 somatoform disorders 57 tegaserod 57 androgen suppression 57 Major Depressive Disorder 57 vasomotor 57 oral prednisolone 57 tipranavir ritonavir 57 RISPERDAL ® 57 Selective serotonin reuptake inhibitors 57 quetiapine XR 57 paroxetine sertraline 57 anticholinergic drugs 57 Tumor Response 57 beta blocker therapy 57 HAQ DI 57 Cognitive behavioral 57 β blockers 57 DMARD therapy 57 paroxetine Paxil 57 nonpharmacologic 57 CCyR 57 platelet reactivity 57 myopathy rhabdomyolysis 57 aripiprazole 57 quetiapine 57 guideline concordant 57 ziprasidone 57 juvenile idiopathic arthritis 57 haematologic 57 aripiprazole Abilify 57 OSAHS 57 antiepileptics 57 elevated transaminases 57 risperidone Risperdal 57 Known hypersensitivity 57 psychoeducation 57 T2DM 57 neuroleptics 57 symptom flare ups 57 symptomatic hyponatremia 57 clomipramine 57 dysphoric 56 psychotherapeutic interventions 56 DAPT 56 intracranial hypertension 56 oxycodone CR 56 tapentadol ER 56 extrapyramidal symptoms 56 somatostatin analogs 56 intranasal corticosteroids 56 perioperatively 56 leukotriene receptor antagonist 56 PASI scores 56 depressive symptomatology 56 Mindfulness Based Cognitive Therapy 56 posttreatment 56 opioid naive 56 carotid angioplasty 56 LTRA 56 acute mania 56 CPAP adherence 56 inhaled bronchodilators 56 Lamotrigine 56 Cognitive Behavior Therapy 56 neurologic progression 56 psychotherapies 56 affective psychoses 56 Adjunctive 56 aldosterone antagonist 56 antiepileptic medications 56 therapeutic regimens 56 pharmacological treatments 56 methotrexate therapy 56 coinfected patients 56 Fluid retention 56 hypertension diabetes mellitus 56 postoperative chemotherapy 56 trials RCTs 56 psychodynamic psychotherapy 56 selective serotonin reuptake inhibitor 56 adverse cytogenetics 56 NUCYNTA R 56 monoamine oxidase inhibitors 56 immunosuppressive therapies 56 serotonin reuptake inhibitor 56 tranylcypromine 56 antithrombotic therapy 56 antidepressive 56 follicular lymphomas 56 symptomatic VTE 56 reflux symptoms 56 paricalcitol 56 hypomanic episodes 56 Quetiapine 56 meta regression 56 immunosuppressive regimen 56 serum estradiol 56 prodromal symptoms 56 nonadherence 56 postoperative AF 56 postprocedure 55 conventional antipsychotics 55 antiarrhythmic drug 55 affective psychosis 55 acute postoperative 55 fludarabine cyclophosphamide 55 androgen deprivation 55 oral naltrexone 55 inotropic agents 55 overactive bladder syndrome 55 INVEGA ™ 55 Schema Therapy 55 salmeterol fluticasone 55 interferon therapy 55 Helicobacter pylori eradication 55 atypical antipsychotic medications 55 therapy CBT 55 adverse perinatal 55 behavioral interventions 55 pharmacologic therapies 55 untreated psychosis 55 Tasigna prolongs 55 Thal Dex 55 moderate renal impairment 55 depressive symptom 55 comorbid conditions 55 systolic hypertension 55 elevated serum creatinine 55 polyarticular 55 EFFEXOR XR 55 SSRI citalopram 55 subsyndromal 55 neurocognitive impairment 55 postsurgical pain 55 aromatase inhibitor therapy 55 Unstable Angina 55 neuroinflammatory 55 opioid dependent 55 paliperidone ER 55 antioxidant supplementation 55 hyperammonemia 55 paliperidone 55 undergoing liver transplantation 55 generalized anxiety disorder GAD 55 imipramine 55 virological response 55 immunosuppressive agents 55 asthma exacerbations 55 HPA axis 55 conventional DMARDs 55 tumor histology 55 glucocorticoid therapy 55 virologic responses 55 akathisia 55 serologically active patients 55 oral anticoagulation 55 colorectal liver metastases 55 N acetylcysteine 55 Relieve Depression 55 depression suicidal ideation 55 antiandrogen 55 dysthymia 55 subthreshold depression 55 ACTEMRA TM 55 NATRECOR R 55 intracerebral haemorrhage 55 serotonin norepinephrine reuptake inhibitors 55 nonmetastatic prostate cancer 55 MGd 55 Zoloft sertraline 55 Sociodemographic 55 Mellaril 55 dual endothelin receptor antagonist 55 topical calcineurin inhibitors 55 imatinib therapy 55 pharmacodynamic parameters 55 olanzapine quetiapine 55 Paliperidone 55 syndromal 55 neuromotor 55 methylphenidate Ritalin 55 Hepatotoxicity 55 tricyclic antidepressant 55 prolactin elevation 55 GH deficiency 55 lipid lowering agents 55 divalproex sodium 55 affective disorders 55 GnRH agonists 55 CLINICAL PHARMACOLOGY 55 Cognitive behavioral therapy 55 cranial radiation 54 proliferative diabetic retinopathy 54 MADRS score 54 symptomatology 54 primary percutaneous coronary 54 LUTS 54 somatostatin analog 54 treating neuropathic pain 54 somatic complaints 54 trastuzumab Herceptin ® 54 biventricular pacing 54 sotalol 54 desvenlafaxine succinate 54 pharmacotherapies 54 intima media thickness 54 psoriatic arthritis PsA 54 varenicline Chantix 54 Cognitive Behavioural Therapy 54 transaminase elevations 54 CIPN 54 mild renal insufficiency 54 aminotransferases 54 insulin detemir 54 recurrent sinusitis 54 tolterodine 54 Prozac fluoxetine 54 tapentadol IR 54 Teriflunomide 54 esophagogastric 54 multivariate analyzes 54 TNF antagonist 54 selective modulator 54 haloperidol Haldol 54 corticosteroid dose 54 antihypertensive therapy 54 cognitive behavioral therapies 54 pharmacotherapy 54 Comorbidity 54 parkinsonian symptoms 54 hemorrhagic complications 54 OAB symptoms 54 echocardiographic parameters 54 octreotide 54 abrupt discontinuation 54 Ziprasidone 54 guanfacine extended release 54 frequent awakenings 54 atherosclerotic renal artery stenosis 54 tic severity 54 recurrent glioblastoma multiforme 54 perioperative complications 54 carotid IMT 54 RLS symptoms 54 analgesic medications 54 opioid naïve 54 KAPIDEX 54 primary aldosteronism 54 typical antipsychotics 54 Depressive symptoms 54 antiretroviral naïve 54 tiagabine 54 PSADT 54 Postmenopausal 54 virological failure 54 D Sequenced Treatment 54 endocrine responsive 54 buprenorphine naloxone 54 Mitral Regurgitation 54 untreated OSA 54 atypical neuroleptics 54 suboptimal adherence 54 phenelzine 54 adenoidectomy 54 daytime somnolence 54 acute subacute 54 left ventricular diastolic 54 Geodon ziprasidone 54 Sertraline 54 Secondary endpoints included 54 VIIBRYD 54 GI motility disorders 54 pharmacological therapies 54 decompensated cirrhosis 54 psychopharmacologic 54 Effexor venlafaxine 54 Rheumatoid Arthritis RA 54 chronicity 54 sertraline Zoloft 54 Retreatment 54 postoperative infections 54 INVEGA ® SUSTENNA ® 54 acute psychosis 54 Pegasys ® 54 maximally tolerated lipid lowering 54 neuropsychological deficits 54 Cognitive impairment 54 Imipramine 54 Di Bisceglie 54 transcranial Doppler ultrasound 54 hepatic metastases 54 Psychiatric Disorders 54 MCyR 54 fluoxetine paroxetine 54 idiopathic Parkinson disease 54 obstructive sleep apnea hypopnea 54 peginterferon 54 inhaled glucocorticoids 54 citalopram 54 bezafibrate 54 antenatal depression 54 Functional Outcomes 54 tipranavir r 54 lipid altering 54 dysthymic disorder 54 ribavirin therapy 54 postoperative pulmonary 54 methotrexate monotherapy 54 preterm neonates 54 detrusor overactivity 54 neuropsychiatric symptoms 54 Secondary Hyperparathyroidism 54 Malignant Glioma 54 insulin glulisine 54 fluoxetine 54 Suicidal ideation 54 Index CDAI 54 olanzapine LAI 54 pimozide 54 hypersomnia 54 subscale scores 54 DPNP 54 convergent validity 54 Neuropsychiatric Inventory 54 PLMs 54 Rate ORR 54 solifenacin 54 oral NSAIDs 54 glycated hemoglobin levels 53 CLBP 53 dopamine antagonists 53 adalimumab 53 Primary endpoints 53 Negative Symptoms 53 Generalized anxiety disorder 53 tricyclic antidepressants 53 antiemetics 53 ADCS CGIC 53 psychiatric comorbidities 53 constipation OIC 53 BEXXAR Therapeutic Regimen 53 weekly subcutaneous injections 53 pharmacological approaches 53 VAPRISOL 53 erlotinib Tarceva 53 anticonvulsant medications 53 nonpharmacological 53 droperidol 53 antidepressant efficacy 53 Anticoagulation 53 Telintra 53 Reduces Mortality 53 PegIFN RBV 53 EEG biofeedback 53 psychiatric comorbidity 53 nondepressed 53 Nesiritide 53 SCr 53 selective reuptake inhibitors 53 imipramine Tofranil 53 nonvertebral fractures 53 PANSS scores 53 Teriparatide 53 administered cetrorelix 53 adjuvant therapies 53 doxorubicin docetaxel 53 QTc intervals 53 corticosteroid therapy 53 antiplatelet therapies 53 intravesical chemotherapy 53 decompensated heart failure 53 MIRAPEX 53 Neuroticism 53 reflux disease GERD 53 Social Phobia 53 PCWP 53 neurocognitive function 53 impaired cognition 53 noncardiovascular mortality 53 Ventricular Arrhythmias 53 ADAS Cog 53 doxorubicin HCl 53 serotonin neurotransmission 53 menopausal symptom 53 pregabalin Lyrica 53 tricyclic antidepressants TCAs 53 headache abdominal pain 53 ICD shocks 53 pharmacologic therapy 53 desipramine 53 nondrug treatments 53 systemic corticosteroid 53 diabetic gastroparesis 53 reuptake inhibitor 53 SRBD 53 conjugated equine estrogen 53 Pharmacotherapy 53 #q# deletion syndrome 53 psychopharmacological 53 Chronic Heart Failure 53 Depressive Symptoms 53 vasomotor symptoms 53 oral corticosteroid 53 Intervention Effectiveness 53 Lu AA# 53 Psychiatric Illness 53 Selective Serotonin Reuptake Inhibitor 53 tic disorders 53 carotid atherosclerosis 53 intact parathyroid hormone 53 IBS symptoms 53 oral antidiabetes 53 Cognitive Behavioral Therapy 53 Estrogen Receptor 53 docetaxel pretreated 53 PYY #-# 53 Mood disorders 53 anticoagulation therapy 53 Paxil paroxetine 53 initiating antiretroviral therapy 53 Montgomery Asberg Depression 53 oral rivaroxaban 53 motivational interviewing 53 adjunctive therapies 53 pharmacological therapy 53 Cholesterol Levels SPARCL 53 electroacupuncture 53 intermittent dosing 53 venlafaxine ER 53 hippocampal atrophy 53 donepezil Aricept 53 MS relapses 53 refractory AML 53 extrapyramidal symptoms EPS 53 Vagus Nerve Stimulation 53 tricyclics 53 sertraline 53 infliximab 53 unfavorable cytogenetics 53 comorbid ADHD 53 alteplase 53 hypothalamic pituitary adrenal axis 53 liver histology 53 Tricyclic antidepressants 53 intravenous cyclophosphamide 53 Brief Psychiatric 53 mirtazapine 53 topical NSAIDs 53 premenopause 53 buproprion 53 riociguat 53 dysthymic 53 biopsychosocial 53 antiplatelet drugs 53 tricyclic 53 poststroke 53 BARI 2D 53 dyslipidaemia 53 symptom severity 53 somatostatin analogues 53 nonepileptic seizures 53 epidural analgesia 53 Pemetrexed 53 lymphocytosis 53 COPD exacerbations 53 Cognitive Behaviour Therapy 53 HBeAg negative patients 53 Exacerbations 53 colorectal adenoma 53 Nonsurgical 53 postoperative complication 53 LATUDA 53 atopic eczema 53 CIMZIA TM certolizumab pegol 53 glycated hemoglobin HbA1c 53 myeloid metaplasia 53 opioid analgesia 53 oral corticosteroids 53 deep venous thromboses 53 Montgomery Åsberg Depression 53 mu opioid agonist analgesics 53 comorbid psychiatric 53 pharmacological intervention 53 cardiac conduction 53 serum cortisol 53 hemoglobin A1c levels 53 Parkinsonian symptoms 53 Abatacept 53 sacral neuromodulation 53 hypometabolism 53 clozapine 53 Y BOCS 53 DAS# remission 53 anticholinergics 53 androgen depletion therapy 53 akinetic mutism 53 biologic DMARDs 53 Bipolar Mania 53 ß blockers 53 neurocognition 53 delayed CINV 53 Treatment Resistant 53 antidepressants fluoxetine 53 psychiatric morbidity 53 antibiotic prophylaxis 53 subclinical hypothyroidism 53 antiandrogens 53 COREG 53 disease modifying antirheumatic 53 chromium picolinate supplementation 53 thiopurine 53 SSRIs selective serotonin 53 CONCERTA 53 intratympanic 53 depression suicidality 53 Psoriasis Area 53 aromatase inhibitors AIs 53 mu opioid 53 HER2 overexpression 53 cilostazol 52 bioavailable testosterone 52 prescribed beta blocker 52 Adult ADHD 52 opiate dependence 52 adenoma recurrence 52 relapsed MM 52 glycoprotein IIb IIIa inhibitors 52 psychoeducational 52 Alequel 52 mcg BID 52 MIRAPEX ER 52 ABVD 52 rhinoconjunctivitis 52 anticholinergic medication 52 FOLFIRINOX 52 subcutaneous immunoglobulin 52 glycosylated hemoglobin levels 52 nefazodone 52 biologic DMARD 52 HIV HCV coinfected 52 antimicrobial prophylaxis 52 thrombocytopenic patients 52 TEAEs 52 paliperidone palmitate 52 T1DM 52 chemotherapy docetaxel 52 chemoradiation 52 postoperative mortality 52 postoperative atrial fibrillation 52 resynchronization therapy 52 Plaquenil 52 dyspareunia 52 venous thromboembolic disease 52 serotonin norepinephrine 52 hyperphenylalaninemia HPA due 52 spinal manipulative 52 Anxiety Depression 52 NMDA antagonists 52 overt hypothyroidism 52 periprocedural 52 Non inferiority 52 myofascial pain syndrome 52 juvenile idiopathic arthritis JIA 52 Dissociation 52 PSA nadir 52 recurrent miscarriage 52 thyrotropin levels 52 hypoxemia 52 Etanercept 52 hematopoietic cancers 52 depressive symptoms 52 tracheal intubation 52 Visual Analogue Scale VAS 52 nonoperative treatment 52 ZOLINZA 52 efalizumab 52 comorbid 52 comorbidity 52 pretreatment serum 52 nociceptive pain 52 CYP#A# inhibitors 52 basal bolus regimen 52 newer atypical antipsychotics 52 VTE prophylaxis 52 baseline LDH 52 Venlafaxine 52 surgical revascularization 52 Secondary efficacy endpoints 52 stable angina 52 urinary symptoms 52 secondary efficacy endpoints 52 Behavior Therapy 52 progesterone receptor negative 52 psychostimulants 52 Refractory Hodgkin Lymphoma 52 anemia hemoglobin 52 lamotrigine 52 danazol 52 cognitive behavioral therapy 52 risperidone 52 nighttime awakenings 52 nonbacterial prostatitis 52 recurrent venous thromboembolism 52 acting insulin analogues 52 #:#-#,# CrossRef Medline [002] 52 azathioprine 52 AGILECT ® 52 posttransplant 52 dosage regimens 52 EBMT criteria 52 labetalol 52 milrinone 52 anxiolytics 52 NNT = 52 glucocorticoid 52 Anticonvulsant 52 Scale PANSS 52 autonomic dysfunction 52 lanreotide 52 desmopressin 52 Muscle relaxants 52 newer atypical antipsychotic 52 Paliperidone ER 52 interstitial brachytherapy 52 APTIVUS R 52 Clinical Outcome 52 metastatic malignant 52 hyperreflexia 52 HRQL 52 prolonged QT interval 52 Comorbidities 52 lipid parameters 52 hyperarousal 52 AA Amyloidosis 52 multisystemic 52 bronchodilator therapy 52 metabolic parameters 52 tamoxifen therapy 52 vagal nerve stimulation 52 ventilator weaning 52 dietary modification 52 shorter telomere length 52 YMRS 52 stone formers 52 migraineurs 52 univariate analyzes 52 somatization disorder 52 Neoadjuvant 52 topical corticosteroids 52 diabetes mellitus DM 52 functional dyspepsia 52 autoimmune thyroiditis 52 unmeasured confounders 52 denileukin diftitox 52 Valproic acid 52 Riluzole 52 hyperactivity impulsivity 52 DMSA 52 mcg kg REBETOL 52 Secondary endpoints 52 TMJD 52 MoxDuo TM IR 52 salivary cortisol 52 progressive dyspnea 52 boosted protease inhibitor 52 olanzapine 52 neurophysiologic 52 thromboprophylaxis 52 compulsive hoarding syndrome 52 severe hepatic dysfunction 52 BENICAR HCT 52 severe exacerbations 52 Shows Statistically Significant 52 HRQoL 52 glatiramer 52 HRQOL 52 Severe Primary IGFD 52 receiving APTIVUS r 52 receptor antagonism 52 stavudine d4T 52 thromboembolic complications 52 intrathecal baclofen 52 underdiagnosis 52 antihypertensive agents 52 postoperative radiotherapy 52 Posttraumatic 52 oxcarbazepine 52 Oxymorphone ER 52 cortical activation 52 Afib 52 cytogenetic response 52 repetitive transcranial magnetic stimulation 52 etanercept 52 A1c levels 52 vaginal hysterectomy 52 BENICAR 52 constipation predominant irritable bowel 52 statins cholesterol lowering 52 nonadherent 52 temporomandibular disorders 52 pulmonary hypertension PH 52 SSRI anti depressants 52 Adverse effects 52 hypochondriasis 52 antiseizure 52 Medication adherence 52 Triptans 52 Secondary endpoints include 52 hip resurfacing arthroplasty 52 attain statistical significance 52 oral antidiabetes drugs 52 surgical debulking 52 CORE OM 52 CIMZIA R 52 hypoperfusion 52 Spinal manipulation 52 oral anticoagulant therapy 52 Mitoxantrone 52 NUCYNTA ™ 52 diagnosing ADHD 52 anthracyclines taxanes 52 NAbs 52 ibandronate 52 transrectal ultrasound guided 52 status epilepticus 52 atherogenic dyslipidemia 52 chronic prostatitis chronic 52 INVEGA 52 LHRH agonists 52 Suicidality 52 suppressive therapy 52 nortriptyline Pamelor 52 Biphasic 52 Sjögren syndrome 52 Antidepressant medications 52 CorVue ™ 52 eszopiclone 52 INVEGA R 52 serum phosphate 52 pulmonary hypoplasia 52 acamprosate 52 percutaneous vertebroplasty 52 antidepressant medications 52 invasive candidiasis 52 suboptimally 52 Duloxetine 52 thoracoscopic lobectomy 52 rheumatoid arthritis osteoarthritis ankylosing 52 nonalcoholic steatohepatitis 52 serum calcium levels 52 hypofractionated radiation 52 bosentan 52 endometrial thickness 52 intensive statin therapy 52 clinicopathological 52 Dialectical Behavior Therapy 52 pramipexole 52 nonoperative 51 psychosocial functioning 51 Health Assessment Questionnaire 51 sulphonylureas 51 Navelbine 51 ventricular tachyarrhythmia 51 postoperative ileus POI 51 TMS Therapy 51 chemoradiation therapy 51 cognitive behavioral 51 elevated creatinine 51 chronic noncancer pain 51 adriamycin 51 genotypic resistance 51 plasma leptin 51 seminomas 51 valproate 51 exploratory endpoints 51 escitalopram Lexapro 51 equianalgesic dose 51 Aripiprazole 51 QT interval prolongation 51 probiotic supplementation 51 anagrelide 51 irritative 51 Psychosocial interventions 51 renal scarring 51 transdermal testosterone 51 Randomized controlled 51 musculoskeletal pain 51 β blocker 51 nonsevere 51 darunavir ritonavir 51 lupus scleroderma 51 perimenopausal women 51 phenothiazines 51 tenecteplase 51 Irritable Bowel 51 hormone deprivation 51 Poisson regression 51 p = .# [002] 51 lamivudine refractory patients 51 Ancoli Israel 51 depressive disorders 51 hip BMD 51 chlorambucil 51 cytopenias 51 Relapse Prevention 51 daytime drowsiness 51 dysrhythmias 51 Excessive daytime sleepiness 51 Acute MI 51 tipranavir 51 concomitant medications 51 NIHSS 51 ULORIC 51 #:#-#,# CrossRef Medline [001] 51 Omalizumab 51 menopausal hot flushes 51 protease inhibitors PIs 51 MAO inhibitors 51 Anti psychotics 51 malabsorptive 51 RLAI 51 antiretroviral naive 51 premorbid 51 CIMZIA ™ 51 TNF alpha inhibitor 51 Methylphenidate 51 somnolence sleepiness 51 somatization 51 nonfatal MI 51 unipolar depression 51 ischemic mitral regurgitation 51 electro acupuncture 51 chronic rhinosinusitis 51 inotropic therapy 51 Ischemic Stroke 51 pulmonary artery banding 51 Panic Disorder 51 ropinirole Requip 51 montelukast 51 ropinirole 51 overt nephropathy 51 SNRIs 51 Treatment Outcome 51 serum IGF 51 Subgroup analysis 51 Erythropoietic therapies may 51 Generalized Anxiety Disorder GAD 51 virologic failure 51 meta analytic 51 acting injectable formulation 51 hypovitaminosis D 51 anticonvulsant medication 51 clozapine Clozaril 51 Newly Diagnosed Multiple Myeloma 51 subclinical cardiovascular disease 51 peri procedural 51 hypoglycaemic episodes 51 lipid abnormalities 51 gastrointestinal dysfunction 51 progressive PsA 51 refractory epilepsy 51 Janssen Risperdal 51 QVAR R 51 strong CYP#A# inducers 51 multivariable adjustment 51 vWD 51 Atomoxetine 51 bronchopulmonary dysplasia BPD 51 unfractionated heparin 51 Dysmenorrhea 51 platelet activation 51 HYVET 51 prescribed opioids 51 radicular pain 51 irbesartan 51 cholinergic tone 51 BPS IC 51 Fingolimod 51 Posttraumatic Stress 51 Adjuvant chemotherapy 51 gastroenterology neurology 51 hepatic fibrosis 51 hemodilution 51 CsA 51 daytime alertness 51 decrements 51 androgen depletion 51 neurodevelopmental impairment 51 highly emetogenic chemotherapy 51 epidural steroid injection 51 serum lipid levels 51 Sentinel Lymph Node Biopsy 51 CR nPR 51 Aggrastat ® tirofiban hydrochloride 51 sociodemographic characteristics 51 rt PA 51 steroid inhalers 51 hyperprolactinemia 51 zonisamide SR 51 abdominal adiposity 51 Zeldox 51 clinically meaningful improvement 51 glucose abnormalities 51 spirometric 51 hypoglycemic events 51 abnormal lipid 51 Psychodynamic 51 albumin excretion rate 51 psychosocial 51 serotonin reuptake inhibitors SSRIs 51 experimentally induced 51 Anti TNF 51 L dopa 51 Improves Outcomes 51 Tolvaptan 51 airway hyperresponsiveness 51 procedural sedation 51 anticlotting drugs 51 noncardiac 51 pharmacokinetic interactions 51 comorbid psychiatric disorders 51 PREZISTA r 51 antiarrhythmic drugs 51 unstable angina UA 51 Divalproex 51 major depressive disorder 51 Rating Scale MADRS 51 neurodevelopmental outcome 51 Cognitive Behavioural Therapy CBT 51 nondiabetic patients 51 chronic renal insufficiency 51 CRF antagonists 51 5 HTTLPR 51 acetabular dysplasia 51 colorectal carcinogenesis 51 neuropsychological assessment 51 autoantibody levels 51 intermittent hypoxia